KLHL2

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, KLHL2 mutation is significantly associated with the drug of many other genes, with 20 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible KLHL2-associated genes across cancer lineages are Niraparib, GSK3337463A, and 123138. Each is linked with KLHL2 in more than 1 cancer types. Because this analysis shows association rather than direction, both KLHL2-to-partner and partner-to-KLHL2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Niraparib grouped by KLHL2-low versus KLHL2-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (KLHL2→partner) and Y-score (partner→KLHL2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINENiraparib →+0.471+2.700.004.03031
LARGE_INTESTINEGSK3337463A →+0.328+2.710.043.02731
LARGE_INTESTINE123138 →+0.304+2.871.030.02131
LARGE_INTESTINEMasitinib →+0.458+2.652.033.04531
LARGE_INTESTINETPCA-1 →+0.540+2.786.023.03731
LARGE_INTESTINEETP-45835 →+0.266+2.652.027.04531
Each partner links to its Q-omics profile. Showing the 6 strongest of 20 associations by consensus.

Niraparib by KLHL2 expression — LARGE_INTESTINE

Box plot of Niraparib in KLHL2-low vs KLHL2-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration